Outlook Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Iselin, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Outlook Therapeutics, Inc. has filed 815 SEC EDGAR filings since 10 Aug 2015

SEC filing history

Showing 26-50 of 815 matching filings.

Per page
25
Current page
2
4

PRIMARY DOCUMENT

Filing date
27 May 2026
Reporting date
26 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37759

PRE 14A

Filing date
22 May 2026
Reporting date
16 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-278340

424B5

Filing date
13 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-583245

D filing

Filing date
07 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-89495

SCHEDULE 13G filing

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-278340

424B5

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-278340

424B5

Filing date
25 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-278340

424B5

Filing date
23 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89495

SCHEDULE 13G/A filing

Filing date
05 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .